Safety of UV1 Vaccination in Combination With Ipilimumab in Patients With Unresectable or Metastatic Malignant Melanoma

NCT02275416 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Melanoma

Interventions

DRUG: Ipilimumab
BIOLOGICAL: UV1 vaccine
BIOLOGICAL: GM-CSF

Sponsor

Ultimovacs ASA

Collaborators

[object Object]